CME Group downgraded by BofA Securities with a new price target
$CME
Investment Bankers/Brokers/Service
Finance
BofA Securities downgraded CME Group from Neutral to Underperform and set a new price target of $177.00 from $212.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/8/2025 | $301.00 | Equal-Weight → Overweight | Morgan Stanley |
| 3/10/2025 | $287.00 | Mkt Perform → Outperform | Raymond James |
| 1/6/2025 | $255.00 → $250.00 | Buy → Neutral | Citigroup |
| 10/8/2024 | $244.00 | Buy → Neutral | Redburn Atlantic |
| 9/27/2024 | $235.00 | Sector Perform | RBC Capital Mkts |
| 9/26/2024 | $221.00 | Hold | TD Cowen |
| 9/3/2024 | $212.00 → $177.00 | Neutral → Underperform | BofA Securities |
| 6/21/2024 | $206.00 → $187.00 | Neutral → Underweight | JP Morgan |
4 - CME GROUP INC. (0001156375) (Issuer)
4/A - CME GROUP INC. (0001156375) (Issuer)
4 - CME GROUP INC. (0001156375) (Issuer)
CHICAGO, March 12, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2025 before the markets open on Wednesday, April 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions. A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing
Record revenue of $6.1 billion for full-year 2024, up 10%CHICAGO, Feb. 12, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2024. The company reported revenue of $1.5 billion and operating income of $947 million for the fourth quarter of 2024. Net income was $875 million and diluted earnings per common share were $2.40. On an adjusted basis, net income was $919 million and diluted earnings per common share were $2.52. Financial results presented on an adjusted basis for the fourth quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1 Total revenue for full-year 2
CHICAGO, Feb. 6, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a first-quarter dividend of $1.25 per share, a 9% increase from the prior level of $1.15 per share. The dividend is payable March 26, 2025 to shareholders of record as of March 7, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest r
CHICAGO, July 8, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Mike Dennis as Global Head, Fixed Income. In this position, Dennis will oversee the company's largest, most actively traded global benchmark futures and options contracts on SOFR and U.S. Treasuries, including the 30-year bond, 10-, 5- and 2-year notes that enable investors to manage risk across the entire U.S. yield curve. He will also lead BrokerTec, the world's most liquid electronic cash trading platform for U.S Treasury benchmarks, E.U., U.K. and U.S. Repo trading. Dennis will report to CME Group Chairman and Chief Executive Officer Terry Duffy and serve on th
CHICAGO, June 3, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of John Ricci as Managing Director and Global Head of Agricultural Products. Reporting to Derek Sammann, Senior Managing Director and Global Head of Commodities Markets, Ricci will be responsible for leading the development, execution and management of the exchange's agricultural business globally. He will be based in Chicago. "We are pleased to welcome John to CME Group," said Derek Sammann, Senior Managing Director and Global Head of Commodities Markets. "Our benchmark agricultural products play a vital role in the global economy, helping our customers manage risk
CHICAGO, May 9, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2024 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Larry G. Gerdes, Daniel R. Glickman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Terry L. Savage, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2025;Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2024;Approved, on an advisory basis, the
In the news release, S&P Global and CME Group to sell OSTTRA to KKR for $3.1 billion, issued 14-Apr-2025 by S&P Global over PR Newswire, we are advised by the company that the tenth paragraph, should read "Barclays and Davis Polk served as financial and legal advisors, respectively, to S&P Global. Citi and Skadden served as financial and legal advisors, respectively, to CME Group. Goldman Sachs & Co. LLC and BofA Securities, and Simpson Thacher & Bartlett served as financial and legal advisors, respectively, to KKR." rather than "Barclays and Davis Polk served as financial and legal advisors, respectively, to S&P Global. Citi and Skadden served as financial and legal advisors, respectively,
NEW YORK, April 14, 2025 /PRNewswire/ -- S&P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider of post-trade solutions for the global OTC market, to investment funds managed by KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, subject to customary purchase price adjustments, which will be divided evenly between S&P Global and CME Group pursuant to their 50/50 joint venture. Established in 2021 as a joint venture between CME Group and S&P Global, OS
Record Europe, Middle East and Africa (EMEA) ADV of 6.5M, up 20% in Q1 2025Record Asia Pacific (APAC) ADV of 2M, up 20% in Q1 2025LONDON and SINGAPORE, April 9, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 8.8 million contracts in Q1 2025, up 19% year on year. Reflecting all trading reported outside the United States, this quarterly record was driven by growth across all asset classes, as well as record quarterly ADV in EMEA, APAC and Canada. Quarterly international records were achieved in Energy, Agricultural and Foreign Exchange products up 29%, 29% and 14% respecti
8-K - CME GROUP INC. (0001156375) (Filer)
DEFA14A - CME GROUP INC. (0001156375) (Filer)
DEF 14A - CME GROUP INC. (0001156375) (Filer)
Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00
Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00
Citigroup downgraded CME Group from Buy to Neutral and set a new price target of $250.00 from $255.00 previously
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
4 - CME GROUP INC. (0001156375) (Issuer)
4/A - CME GROUP INC. (0001156375) (Issuer)
4 - CME GROUP INC. (0001156375) (Issuer)